Keep it real
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My gut feeling tells me that in the absence of further news in the next couple of weeks, pps support will not hold. Too much manipulation to get in cheaper.
Why the high burn cash rate? 4mil seems a lot!
Got back in after the dilution, and doubled up today at 7.2
Thanks Blackdeath for the remarks, made me set the target for adding.
Well now we know, so no need to repeat it every single day!
the SA article was nothing but amateur trash. Remember the Advaxis hit piece in January? now that had effect, albeit very short.
I have been surprised that no hit pieces have come out of AFu###stein.
Great!
I am intrigued with the 'uplisting coming' as we do not meet the requirements.
Sure hope they will not do a quick RS! Plenty of natural growth possible to get to 3 or 4$
they were really cheap earlier in the year and still trading sub .50 3 weeks ago...
why is every post you make a double post??
You are confusing me doc
September for initial data release has become unrealisitic ( given that we are still waiting on 1 st patient enrollment and then need at least 12 weeks). That has already been established
As for interim data being statistically significant; no it will not be. However the full data will be. This has already been establised
So why keep rehashing?
Its attempt to bash but a very poor one. A 9 year old could do better
You are right that we need data confirmation and reproduction. That will set us up for a bright future
But who will control the pps between now and next data update?
Right, MM
I'll be waiting... Still I am curious what created the spike in vol since late June.
sorry how did you come to the conclusion that this consolidation period is brief?
Correct on the science, but no direct relationship to pps. Markets dont work on logic!
1y plus since vgx3100 results. Where is the peer reviewed paper?
Where is the peer review paper on universal influenza vaccine?
Anybody that can post the content here?
this time zero mention of any patent issue. Makes him look a bit silly to me as he was all over dr Missling last time.
Basic Basic uber-basic OTC rule: NEVER use a stop because the manipulation is too big.
Something I learned from stockreversals is to use stop-on-close. If in the last 30 trading minutes price is still below your mental stop, then get out.
There has NEVER been a stock like this
It sounds a bit like saying Titanic is unsinkable.
I do not mean there was any misleading involved!
Sure sounds like its the Australian connection
Good find!
They seem to be a patient organization so I don't know how trustworthy and knowledgable they would be on p3 size and location?
Well I hope the preliminary data will be confirmed. It is not a sure thing yet.
Well at least you seem to have a consistent trading pattern!
Well I read your post with great care and had my orders in, so thanks Tom!
Seems pretty amazing how the volume continues to be there. My gut says we will see more attacks but maybe not to 1.1
Possibly, but not conviced, they have the data already last December and held it back. Why?
We have the only drug that works
No, we have preliminary data suggesting that it works. One cannot conclude after 12 patients that a drug works, full stop. This will have to be confirmed subsequently.
I was referring to what Dr L said referring to patient size. My comparison was with AVXL who has skyrocketed on interim data release. (data based on 12 patients and 10 responding). My hope is it will be as good, but one never knows for a fact until it is released.
Sure the same could happen to ONCS when interim data gets released. However I do believe that will only be towards the end of the year. We are still waiting on the 1st patient, then another 12 weeks before measurement...
The full trial with 41 patients will be statistically powered, however interim releases rarely are.
As I see no further value creating catalyst until we get the p2b data, I have exited. Will re-enter towards the end of the year.
so are you 'sucking' as you phrased it so eloquently ?
I am happy exiting last week. Not much incentive in the next couple of months untill we get interim data (which I expect by year end and not statistically significant)
seriously?
these big boys are so predictable
But if you look at it from a chart perspective: the big run up, the walking down...
I do hope we will not see sub 1$ and that the similarity ends there.
this is one of the biggest drawbacks of being an OTC stock and a pretty good reason alone to get uplisted: market manipulation. It's beyond me why the SEC lets them get away with it, but it is what it is.
Is it just me or is that chart showing a little too much similarity to the TPIV-episode last month?
Sorry but you are mistaken, eg
Juno was approved for a pivotal p2 last week in acute lymphoblastic leukemia with 90 patient size
Investors into AVXL are happy so far with interim data of 12 patients (out of 32) in their Alzheimers trial.
So it isnot beyong the realm of possibilites if ONCS were to deliver as good results...
Question to the board regarding FDA. As Alzheimers has become a major focal point, is it possible that the FDA changes our current p2 trial into a pivotal trial? Is that uberhaupt possible?
My expectation is for full results to be announced mid to end October on a big conference. If this for some reason were not to be possible, there might be an interim update earlier, preceded by a pr to announce.
But I am speculating here!
These are my main reasons why an uplist is a good idea
1) better exposure (okay we can't complain lately ;) )
2) the bigger funds require Nasdaq listing and min 5$ pps
3) a lot less market manipulation (again so far no complaints, although I do believe it will happen)
The goal is stated to uplist to Nasdaq, however I do not believe it was stated that it has to happen in 2015
What the plan is to achieve is unknown to me.
I keep hitting the same nail that we have to go on facts. Sorry wanna keep it real and both feet on the ground.
Untill June 30th we all expected first interim data in September, then that got pushed forward to July 22nd
Then on July 22nd they said full data by year end. That is all we know
Now you can go and speculate that again they will release early,... Sure that is a possibility, and I hope it happens, but untill a pr is released telling us the date, we have to go with year end.
Anything else is whishfull thinking